Pullulan regenerative matrix

Patent metadata

Field	Value
Publication number	US-9636362-B2
Application number	US-93273611-A
Country	US
Kind code	B2
Filing date	Mar 3, 2011
Priority date	Mar 4, 2010
Publication date	May 2, 2017
Grant date	May 2, 2017

Abstract

Compositions and methods are provided for the manufacture and use of a pullulan-based collagen hydrogel film with controlled porosity. The hydrogel is fabricated with salt-induced phase inversion and cross-linking to form a reticular scaffold. This soft collagen scaffold displays excellent handling characteristics, durability, and a porous dermal-like ultrastructure that is maintained in vitro. Cells, including cells involved in tissue repair, are viably sustained within the scaffold. The hydrogel films are biodegradable, and find particular use in wound healing, where the hydrogel scaffold can be replaced by dermal cells over time.

First claim

What is claimed is:

1. A composition for wound healing comprising:
a pullulan-collagen hydrogel film with controlled porosity which is cross-linked to form a reticular scaffold wherein pullulan and collagen are organized around salt crystals in an interconnected network such that the reticular scaffold is formed to define pores following salt dissolution and wherein said hydrogel comprises collagen at a concentration of from about 1 to about 12.5%; and
regenerative cells within the pores.

2. The composition of claim 1 , wherein the pores of from about 25 μm to about 50 μm in diameter.

3. The composition of claim 1 , wherein scaffold porosity of said hydrogel ranges from about 50% to about 85%.

4. The composition of claim 1 , wherein the regenerative cells are stem or progenitor cells.

5. The composition of claim 4 , wherein the regenerative cells are mesenchymal stem cells.

6. The composition of claim 1 , where the hydrogel further comprises regenerative growth factors.

7. The composition of claim 6 , wherein the regenerative growth factors are printed on the hydrogel by micro-contact printing.

8. The composition of claim 6 , wherein the regenerative growth factors include a vascular endothelial growth factor (VEGF).

9. The composition of claim 1 , wherein the hydrogel further comprises an antimicrobial agent.

10. The composition of claim 1 , further comprising a dressing suitable for wound repair.

11. The composition of claim 10 , wherein the dressing comprises a breathable protective layer.

12. A composition for wound healing comprising:
a pullulan-collagen hydrogel film with controlled porosity which is cross-linked to form a reticular scaffold wherein pullulan and collagen are organized around salt crystals in an interconnected network such that the reticular scaffold is formed to define pores following salt dissolution and wherein said hydrogel comprises collagen at a concentration of from about 2.5 to about 10%; and
regenerative cells within the pores.

13. The composition of claim 12 , wherein the pores of from about 25 μm to about 50 μm in diameter.

14. The composition of claim 12 , wherein scaffold porosity of said hydrogel ranges from about 50% to about 85%.

15. The composition of claim 12 , wherein the regenerative cells are stem or progenitor cells.

16. The composition of claim 15 , wherein the regenerative cells are mesenchymal stem cells.

17. The composition of claim 12 , where the hydrogel further comprises regenerative growth factors.

18. The composition of claim 17 , wherein the regenerative growth factors are printed on the hydrogel by micro-contact printing.

19. The composition of claim 17 , wherein the regenerative growth factors include a vascular endothelial growth factor (VEGF).

20. The composition of claim 12 , wherein the hydrogel further comprises an antimicrobial agent.

21. The composition of claim 12 , further comprising a dressing suitable for wound repair.

22. The composition of claim 21 , wherein the dressing comprises a breathable protective layer.

Assignees

• Gurtner Geoffrey C
• Bhatt Kirit
• Rajadas Jayakumar
• Univ Leland Stanford Junior

Inventors

• Gurtner Geoffrey C
• Bhatt Kirit
• Rajadas Jayakumar

Classifications

• A61P31/04

  Antibacterial agents · CPC title

• A61P31/00

  Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title

• A61K38/39

  Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG] · CPC title

• A61K9/7007

  Drug-containing films, membranes or sheets (A61K9/0041, A61K9/0043, A61K9/006, A61K9/0063 take precedence) · CPC title

• A61L15/40

  containing ingredients of undetermined constitution or reaction products thereof {, e.g. plant or animal extracts} · CPC title